<DOC>
	<DOCNO>NCT00993785</DOCNO>
	<brief_summary>To evaluate product performance safety Catheter Design treatment single coronary lesion .</brief_summary>
	<brief_title>CoStar Catheter System Evaluation</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>1 . Patient ≥18 year age . 2 . Eligible percutaneous coronary intervention ( PCI ) . 3 . Documented stable unstable angina pectoris ( Canadian Cardiovascular Society Classification [ CCS ] 1 , 2 , 3 , 4 ) , document ischemia , document silent ischemia . 4 . Left ventricular ejection fraction ( LVEF ) ≥25 % document within last 6 week . 5 . Acceptable candidate coronary artery bypass graft surgery ( CABG ) . 6 . Patient understand study requirement treatment procedure provide write Informed Consent use form approve local Institutional Review Board Ethics Committee studyspecific test procedure perform . 7 . Willing comply specify followup evaluation . Inclusion Criteria ( Angiographic ) : 1 . A single de novo lesion per study subject may treat study device . 2 . Each target lesion may compose multiple lesion must completely coverable one ( 1 ) study stent . 3 . Cumulative target lesion length per vessel ≤24 mm base visual estimate . 4 . RVD ≥2.5 mm ≤3.0 mm base visual estimate . 5 . Target lesion diameter stenosis ≥50 % &lt; 100 % base visual estimate . 6 . Target vessel undergone prior revascularization within precede 6 month . 7 . Target lesion must minimum 10 mm distance previously treat segment target vessel 1 . Known sensitivity cobalt chromium , paclitaxel polymeric matrix : PLGA . 2 . Planned treatment PCI device target vessel ( ) . 3 . Acute MI within 72 hour prior index procedure define presence new pathologic Q wave , creatinine kinase ( CK ) &gt; 2 time laboratory upper limit normal elevate MB . 4 . The patient cardiogenic shock . 5 . Cerebrovascular Accident ( CVA ) within past 6 month . 6 . Acute chronic renal dysfunction ( creatinine &gt; 2.0 mg/dl &gt; 150 µmol/L ) . 7 . Contraindication ASA clopidogrel . 8 . Thrombocytopenia ( platelet count &lt; 100 , 000/mm3 ) . 9 . Active gastrointestinal ( GI ) bleed within past three month . 10 . Any prior true anaphylactic reaction contrast agent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>